List of insiders holdings for PIERIS PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC ISALY SAMUEL D 10% Owner | 2018-09-27 16:43:06 | 2,455,900 0 | 2,455,900 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC See Remarks 10% Owner | 2018-09-27 16:43:06 | 2,455,900 0 | 2,455,900 | Form 13D |
| Aquilo Capital Management LLC 10% Owner | 2024-02-14 16:37:34 | 1,126,761 0 | 1,126,761 | Form 13G |
| Yoder Stephen S. Chief Executive Officer | 2023-02-28 17:09:07 | 634,021 0 | 634,021 | Form 4 |
| Knopf Claude Chief Business Officer | 2016-11-30 20:24:21 | 500,000 0 | 500,000 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2024-05-17 17:07:11 | 257,622 0 | 257,622 | Form 13G |
| Bures Thomas Chief Financial Officer | 2023-02-28 17:39:15 | 249,080 0 | 249,080 | Form 4 |
| Kaufmann Hitto Chief Scientific Officer | 2023-02-28 17:35:58 | 249,080 0 | 249,080 | Form 4 |
| Mousa Ahmed Chief Business Officer | 2023-02-28 17:31:30 | 249,080 0 | 249,080 | Form 4 |
| Olwill Shane Chief Development Officer | 2023-02-28 17:23:53 | 249,080 0 | 249,080 | Form 4 |
| Reine Allan Chief Financial Officer | 2019-02-28 17:24:24 | 162,500 0 | 162,500 | Form 4 |
| Dellora Investments LP 10% Owner | 2024-11-18 16:16:52 | 0 141,079 | 141,079 | Form 3 |
| Matis Louis Chief Development Officer | 2019-02-28 17:25:09 | 96,500 0 | 96,500 | Form 4 |
| Barbier Ann Director | 2023-06-23 16:47:16 | 40,000 0 | 40,000 | Form 4 |
| Kiener Peter A Director | 2023-06-23 16:46:34 | 40,000 0 | 40,000 | Form 4 |
| KIRITSY CHRISTOPHER P Director | 2023-06-23 16:46:13 | 40,000 0 | 40,000 | Form 4 |
| Richman Michael Director | 2023-06-23 16:45:50 | 40,000 0 | 40,000 | Form 4 |
| Said Maya R. Director | 2023-06-23 16:45:37 | 40,000 0 | 40,000 | Form 4 |
| Sherman Matthew L Director | 2023-06-23 16:45:31 | 40,000 0 | 40,000 | Form 4 |
| Takke Christina Director | 2015-06-29 21:22:52 | 30,000 0 | 30,000 | Form 3 |
| ADAMS JULIAN Director | 2018-01-29 16:40:30 | 20,000 0 | 20,000 | Form 4 |
| Prelack Steven Director | 2019-01-29 17:42:26 | 20,000 0 | 20,000 | Form 4 |
| BIZZARI JEAN-PIERRE Director | 2020-01-28 16:19:48 | 20,000 0 | 20,000 | Form 4 |
| ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 2024-08-12 18:48:13 | 0 15,067 | 15,067 | Form 4 |
| Khuong Chau Quang Director 10% Owner | 2017-10-27 16:26:13 | 6,115 0 | 6,115 | Form 4 |
| Demuth Tim Chief Medical Officer | 2022-05-16 20:19:05 | 6,000 0 | 6,000 | Form 4 |
| DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer | 2016-06-15 17:00:41 | 5,000 0 | 5,000 | Form 4 |
| GERAGHTY JAMES A Director | 2024-10-28 17:18:29 | 1 0 | 1 | Form 4 |
| THIBAULT LANCE E Acting Chief Financial Officer | 2017-02-13 18:00:41 | 0 0 | 0 | Form 3 |